Logo

American Heart Association

  2
  0


Final ID: LBP67

Liquid embolic related microcatheter retention rates in neurovascular disease: a systematic review and meta-analysis

Abstract Body: Background: Intracranial endovascular embolization is commonly performed to treat neurovascular arterial or venous diseases with various liquid embolic agents (LEAs) and techniques, some that polymerize in minutes, while others take substantially longer. Microcatheter retention is a feared complication with several case reports, but true rates being unknown. The aim of this study was to systematically compare microcatheter retention rates for different LEAs.
Methods: A systematic review of microcatheter retention for any neurovascular application was performed using PubMed and Europe PubMed Central on the Nested Knowledge platform for articles until October 2024. Studies were included if any LEA was used in any neurovascular disease, and reported on any microcatheter complications. The number of total patients and those (if any) in which the microcatheter was glued in or retained were extracted. Statistical analysis was performed to compare LEAs with at least 5 studies using a one-way ANOVA test for differences assuming unequal variances with the Games-Howell method.
Results: A total of 1433 articles were screened, of which 61 were included for analysis. Overall microcatheter retention was 5.0% (n=2,760 patients). Five LEAs were grouped in 6 categories: Cyanoacrylate (n=16 studies, 578 patients), Onyx (n=34 studies, 1497 patients), Onyx and/or cyanoacrylate (n=7 studies, 538 patients), PHIL (n=2 studies, 62 patients), SQUID (n=1 study, 30 patients), not specified (n=2 studies, 55 patients). Using categories with at least 5 studies, microcatheter retention rate using Onyx was 70% more than cyanoacrylate (nBCA) but not statistically significant (6.05% vs 3.56%, p=0.126). However, the studies in which either Onyx or nBCA were used had significantly lower microcatheter retention rates compared to Onyx alone (2.69% vs 6.05%, p=0.008).
Conclusions: Microcatheter retention is a complication encountered by Onyx or nBCA by approximately 1 in 20 patients, trending lower for nBCA vs Onyx, though non-significant.
  • Mirza, Mahmood  ( Johnson and Johnson , Galway , Ireland )
  • Ulfert, Christian  ( Johnson and Johnson , Galway , Ireland )
  • Brouwer, Patrick A.  ( Johnson and Johnson , Irvine , California , United States )
  • Author Disclosures:
    Mahmood Mirza: DO have relevant financial relationships ; Employee:Johnson and Johnson:Active (exists now) | Christian Ulfert: DO have relevant financial relationships ; Employee:Johnson & Johnson:Active (exists now) | Patrick A. Brouwer: DO have relevant financial relationships ; Employee:JnJ MedTech Neurovascular:Active (exists now)
Meeting Info:
Session Info:

Late-Breaking Science Posters

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)